(Circulation. 1998;98:2883-2890.)
© 1998 American Heart Association, Inc.
Basic Science Reports |
Restoration of E2F Expression Rescues Vascular Endothelial Cells From Tumor Necrosis Factor-
–Induced Apoptosis
From the Department of Medicine, Division of Cardiovascular Research, St. Elizabeth's Medical Center, Boston, Mass.
Correspondence to Douglas W. Losordo, MD, Department of Medicine, Division of Cardiovascular Research, St. Elizabeth's Medical Center, 736 Cambridge St, Boston, MA 02135. E-mail dlosordo{at}opal.tufts.edu
Background—Normally, quiescent
endothelial cells (EC) line the inner surface of
arteries and protect against thrombosis and neointimal
growth. A variety of noxious stimuli, including balloon angioplasty,
may compromise EC integrity, thereby initiating proliferation and
triggering the local release of cytokines, including tumor
necrosis factor- (TNF-).
Methods and Results—In vivo blockade of TNF- using a soluble
receptor molecule results in accelerated
reendothelialization at sites of balloon angioplasty,
suggesting an important physiological role of
TNF- in attenuating regrowth of endothelium after
balloon angioplasty. Our studies reveal that TNF-, an
apoptosis-inducing cytokine, induces G1 cell-cycle
arrest in proliferating EC. Quiescent EC are relatively immune to
TNF-induced apoptosis versus proliferating EC, which display
repression of the E2F transcription factor coincident with TNF-induced
apoptosis and cell-cycle arrest. We also show that in this
setting, E2F overexpression exerts a survival effect in proliferating
EC and restores cell-cycle progression, in direct contrast to results
of prior reports, which revealed that deregulated expression of E2F in
normally cycling cells induces apoptosis.
Conclusions—These data demonstrate that TNF-induced apoptosis is highly dependent on cell-cycle activity and that E2F can function as survival factor under certain conditions.
Key Words: apoptosis • cells • endothelium • tumor necrosis factor • angioplasty
This article has been cited by other articles:
 |
|
 |
|
  G. Qin, R. Kishore, C. M. Dolan, M. Silver, A. Wecker, C. N. Luedemann, T. Thorne, A. Hanley, C. Curry, L. Heyd, et al. Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF PNAS, July 18, 2006; 103(29): 11015 - 11020. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Kishore, C. Luedemann, E. Bord, D. Goukassian, and D. W. Losordo Tumor Necrosis Factor-Mediated E2F1 Suppression in Endothelial Cells: Differential Requirement of c-Jun N-Terminal Kinase and p38 Mitogen-Activated Protein Kinase Signal Transduction Pathways Circ. Res., November 14, 2003; 93(10): 932 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Stanelle, T. Stiewe, F. Rodicker, K. Kohler, C. Theseling, and B. M. Putzer Mechanism of E2F1-induced apoptosis in primary vascular smooth muscle cells Cardiovasc Res, August 1, 2003; 59(2): 512 - 519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Goukassian, R. Kishore, K. Krasinski, C. Dolan, C. Luedemann, Y.-s. Yoon, M. Kearney, A. Hanley, H. Ma, T. Asahara, et al. Engineering the Response to Vascular Injury: Divergent Effects of Deregulated E2F1 Expression on Vascular Smooth Muscle Cells and Endothelial Cells Result in Endothelial Recovery and Inhibition of Neointimal Growth Circ. Res., July 25, 2003; 93(2): 162 - 169. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Funke-Kaiser, F. Reichenberger, K. Kopke, S.-M. Herrmann, J. Pfeifer, H.-D. Orzechowski, W. Zidek, M. Paul, and E. Brand Differential binding of transcription factor E2F-2 to the endothelin-converting enzyme-1b promoter affects blood pressure regulation Hum. Mol. Genet., February 15, 2003; 12(4): 423 - 433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Chen, C. Capps, J. T. Willerson, and P. Zoldhelyi E2F-1 Regulates Nuclear Factor-{kappa}B Activity and Cell Adhesion: Potential Antiinflammatory Activity of the Transcription Factor E2F-1 Circulation, November 19, 2002; 106(21): 2707 - 2713. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Kishore, I. Spyridopoulos, C. Luedemann, and D. W. Losordo Functionally Novel Tumor Necrosis Factor-{alpha}-Modulated CHR-Binding Protein Mediates Cyclin A Transcriptional Repression in Vascular Endothelial Cells Circ. Res., August 23, 2002; 91(4): 307 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Amant, P. Holm, S.-h. Xu, N. Tritman, M. Kearney, and D. W. Losordo Estrogen Receptor-Mediated, Nitric Oxide-Dependent Modulation of the Immunologic Barrier Function of the Endothelium: Regulation of Fas Ligand Expression by Estradiol Circulation, November 20, 2001; 104(21): 2576 - 2581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Krasinski, I. Spyridopoulos, M. Kearney, and D. W. Losordo In Vivo Blockade of Tumor Necrosis Factor-{alpha} Accelerates Functional Endothelial Recovery After Balloon Angioplasty Circulation, October 9, 2001; 104(15): 1754 - 1756. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Spyridopoulos, P. Mayer, K. S. Shook, D. I. Axel, R. Viebahn, and K. R. Karsch Loss of cyclin A and G1-cell cycle arrest are a prerequisite of ceramide-induced toxicity in human arterial endothelial cells Cardiovasc Res, April 1, 2001; 50(1): 97 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Spyridopoulos, J. Wischhusen, B. Rabenstein, P. Mayer, D. I. Axel, K.-U. Frohlich, and K. R. Karsch Alcohol Enhances Oxysterol-Induced Apoptosis in Human Endothelial Cells by a Calcium-Dependent Mechanism Arterioscler. Thromb. Vasc. Biol., March 1, 2001; 21(3): 439 - 444. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Levkau, K. J. Garton, N. Ferri, K. Kloke, J.-R. Nofer, H. A. Baba, E. W. Raines, and G. Breithardt xIAP Induces Cell-Cycle Arrest and Activates Nuclear Factor-{{kappa}}B : New Survival Pathways Disabled by Caspase-Mediated Cleavage During Apoptosis of Human Endothelial Cells Circ. Res., February 16, 2001; 88(3): 282 - 290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Shelat, T.-J. Liu, D. L. Hickman-Bick, M. K. Barnhart, T. Vida, P. M. Dillard, J. T. Willerson, and P. Zoldhelyi Growth Suppression of Human Coronary Vascular Smooth Muscle Cells by Gene Transfer of the Transcription Factor E2F-1 Circulation, January 23, 2001; 103(3): 407 - 414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Morita, H. Kurihara, S. Yoshida, Y. Saito, T. Shindo, Y. Oh-hashi, Y. Kurihara, Y. Yazaki, and R. Nagai Diet-Induced Hyperhomocysteinemia Exacerbates Neointima Formation in Rat Carotid Arteries After Balloon Injury Circulation, January 2, 2001; 103(1): 133 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Leranth, R. H. Roth, J. D. Elsworth, F. Naftolin, T. L. Horvath, and D. E. Redmond Jr Estrogen Is Essential for Maintaining Nigrostriatal Dopamine Neurons in Primates: Implications for Parkinson's Disease and Memory J. Neurosci., December 1, 2000; 20(23): 8604 - 8609. [Abstract] [Full Text] [PDF]
|
|